The 2025 GLP-1 Weight Loss Guide: Ozempic, Wegovy, Mounjaro, Eligibility & Side Effects Explained

GLP-1 Weight Loss Treatments Abroad in 2025: Complete Guide to Ozempic, Wegovy & Mounjaro with Best Clinic Abroad

Over the past few years, GLP-1–based weight loss injections such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have transformed obesity care worldwide. They are no longer viewed as diabetes-only medications—these drugs are now widely recognized for their ability to help many patients lose 15–25% of their body weight when combined with lifestyle support.

Meanwhile, obesity remains a rising global health challenge, affecting millions of people across all regions. This has led many patients to seek affordable and well-structured obesity treatment programs abroad, including GLP-1 therapy.

This guide explains, step by step:

What GLP-1 and dual GIP/GLP-1 weight-loss medications are

Who qualifies for them

What results you can expect

How treatment works

Safety considerations

How structured GLP-1 programs operate abroad

Global cost comparisons

How Best Clinic Abroad supports patients

What Are GLP-1 and Dual GIP/GLP-1 Drugs?

GLP-1 Receptor Agonists

GLP-1 receptor agonists mimic a naturally occurring hormone that regulates:

Appetite

Fullness

Gastric emptying

Blood sugar levels

Originally created for diabetes, GLP-1 medications now play a major role in evidence-based weight management.

Common GLP-1 medications used for weight loss include:

Semaglutide (Wegovy, Ozempic)

Liraglutide (Saxenda)

Dual GIP/GLP-1 Receptor Agonists (Tirzepatide)

Tirzepatide activates two hormone receptors (GIP and GLP-1), enhancing weight loss compared to GLP-1 medications alone.

Common brands:

Mounjaro

Zepbound

These medications show some of the highest weight-loss results in obesity treatment.

Who Is Eligible for GLP-1 Weight-Loss Therapy?

Global obesity guidelines generally support GLP-1 medications for adults with:

BMI ≥ 30, or

BMI ≥ 27 with weight-related health conditions such as hypertension, type 2 diabetes, or sleep apnea

Candidates should also:

Have tried lifestyle changes without lasting success

Undergo medical screening to evaluate safety

Commit to long-term weight-management strategies

GLP-1 medications are recommended as part of a comprehensive treatment plan, not as a standalone solution.

Expected Weight Loss Results

Semaglutide (Wegovy)

Average weight loss: around 15% of total body weight after about 1 year.

Example: A patient weighing 120 kg may lose around 18 kg on average.

Tirzepatide (Mounjaro / Zepbound)

Average weight loss: 20–22% of total body weight, often more than semaglutide.

Example: A patient weighing 120 kg may lose 24–27 kg on average.

Liraglutide (Saxenda)

Average weight loss: 6–8%, lower than weekly GLP-1 injections but still beneficial.

How GLP-1 Medications Work (Step-by-Step)

GLP-1 and dual agonist drugs affect multiple systems in the body:

Reduce appetite
They influence appetite centers in the brain, decreasing hunger.

Increase fullness
They slow the movement of food from the stomach, helping patients feel full longer.

Support blood sugar control
They stimulate insulin appropriately and help stabilize cravings.

Improve cardiometabolic health
They support reductions in blood pressure, cholesterol, and inflammation.

These combined effects lead to sustainable, clinically meaningful weight loss.

Treatment Protocols and Dosing

Semaglutide (Wegovy)

Typical escalation:

Weeks 1–4: 0.25 mg

Weeks 5–8: 0.5 mg

Weeks 9–12: 1.0 mg

Weeks 13–16: 1.7 mg

Week 17+: 1.7 or 2.4 mg weekly (maintenance dose)

Tirzepatide (Mounjaro / Zepbound)

Typical escalation:

Start at 2.5 mg weekly

Gradually increase to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, up to 15 mg weekly

Treatment Duration

Noticeable results: 3–6 months

Maximum results: 12–18 months

Many patients require long-term continuation to maintain weight loss

Safety, Side Effects and Precautions

Common Side Effects

Usually mild and related to digestion:

Nausea

Vomiting

Diarrhea or constipation

Bloating

Reduced appetite

These often improve as your body adjusts.

Serious Risks (Less Common)

Gallbladder issues

Pancreatitis

Worsening of existing diabetic eye disease

Rare thyroid-related risks (in specific genetic conditions)

Who Should Avoid GLP-1 Medications

Patients with:

History of medullary thyroid carcinoma

MEN2 syndrome

Pancreatitis

Severe gastrointestinal illness

Pregnancy or breastfeeding

GLP-1 medications must only be used when prescribed by licensed medical professionals.

Why Patients Choose GLP-1 Treatment Abroad

Lower Costs

In some countries, GLP-1 medications can cost more than 1,300–1,600 USD per month without insurance.
Many international destinations offer:

Lower medication prices

Comprehensive medical packages

Bundled follow-up care

Faster Access

Reduced waiting times, quicker consultations, and coordinated care attract many patients.

Structured Weight-Loss Programs

A high-quality GLP-1 program abroad includes:

Medical evaluation

Laboratory testing

Medication initiation

Dietitian guidance

Psychological support

Long-term follow-up

Step-by-Step GLP-1 Treatment Journey with Best Clinic Abroad

Step 1: Pre-Screening

Patients share:

Weight, height, BMI

Current diagnoses

Medication list

Previous weight-loss attempts

Medical teams assess suitability and identify risks.

Step 2: Remote Medical Consultation

A specialist explains:

Expected results

Risks and side effects

Medication choices

Travel timing

Additional recommended evaluations

Step 3: Travel Planning

Best Clinic Abroad arranges:

Appointments

Hospital selection

Transportation assistance

Accommodation guidance

Step 4: On-Site Assessment

May include:

Full medical history

Blood tests

Ultrasound or ECG if needed

Meetings with nutrition and psychology specialists

Step 5: Medication Initiation

Patients receive:

First supervised injection

Training on self-administration

A personalized titration schedule

Written safety instructions

Step 6: Monitoring During Stay

Clinicians track:

Side effects

Tolerance

Hydration

Diet adjustments

Step 7: Long-Term Online Follow-Up

After returning home, patients receive:

Scheduled teleconsultations

Guidance for dose increases

Monitoring of progress

Support for lifestyle changes

Global Cost Comparison

While costs vary, general trends include:

United States: highest out-of-pocket expenses

Europe, Turkey, Latin America: significantly lower medication and consultation costs

Many clinics abroad offer packages combining tests, consultations, the first month of medication, and continuing follow-up

Working with Best Clinic Abroad allows patients to compare multiple countries to find the most affordable and safest option.

Questions to Ask Before Choosing a Clinic Abroad

Is the clinic accredited?

Are medications original and sourced from licensed pharmacies?

What is included in the total cost?

Who will provide follow-up after I return home?

How many GLP-1 patients has the clinic treated?

How does the clinic manage complications?

When GLP-1 Treatment Alone Is Not Enough

GLP-1 medications may be combined with:

Nutrition programs

Psychological counseling

Sleep apnea management

Bariatric surgery (for severe obesity)

A multidisciplinary approach often provides the best long-term results.

Final Thoughts

Obesity is a chronic medical condition requiring long-term management.

GLP-1 and dual agonist medications offer powerful, evidence-based weight-loss support.

When combined with structured lifestyle programs, they can help many patients achieve 15–25% total body weight loss.

Medical tourism allows access to high-quality, affordable, comprehensive obesity treatment programs abroad.

Best Clinic Abroad helps patients navigate options, choose safe accredited clinics, and continue follow-up after returning home.